Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cleo Laskari is active.

Publication


Featured researches published by Cleo Laskari.


Circulation | 1997

Two- and Three-Dimensional Transesophageal Echocardiography in Patient Selection and Assessment of Atrial Septal Defect Closure by the New DAS–Angel Wings Device Initial Clinical Experience

Giuseppina Magni; Ziyad M. Hijazi; Natesa G. Pandian; Alain Delabays; Lissa Sugeng; Cleo Laskari; Gerald R. Marx

BACKGROUND Transcatheter closure of atrial septal defects (ASDs) has been feasible and successful. Two-dimensional echocardiography (2DE) was applied to patients before selection and during device deployment. Three-dimensional echocardiography (3DE) can provide unique anatomic perspectives that might aid in improving device closure of ASDs. METHODS AND RESULTS Twenty-two consecutive patients were enrolled in an initial protocol for ASD device closure by the new DAS-Angel Wings occluder device. On the basis of transesophageal (TEE) 2DE and 3DE, 13 patients were considered eligible for device closure (9 secundum ASDs and 4 with patent foramen ovale associated with a cerebral vascular accident). Maximal ASD diameter and surrounding rim tissues were compared by TEE 2DE and 3DE and with balloon sizing measurements at catheterization. ASD size measured by TEE 2DE and 3DE correlated well (y = 1.0x + 0.049, r = .95), with good limits of agreement. However, balloon-stretched diameter measurements were systematically larger than echocardiographic measurements. Rim tissue measurements correlated well; however, TEE 3DE could demonstrate the entire shape and perimeter of the defect. Two-dimensional imaging provided reliable information during device deployment and for closure of small ASDs. However, 3DE was superior for imaging the device, especially when abnormally placed. CONCLUSIONS Three-dimensional imaging provides unique images and projections that were essential for understanding the spatial relationship of the device to the atrial septum. Three-dimensional echocardiography significantly enhanced our understanding of two-dimensional images and provided an imaging conceptualization that should aid in future development of device closures.


American Journal of Cardiology | 1999

Three-dimensional echocardiographic analysis of valve anatomy as a determinant of mitral regurgitation after surgery for atrioventricular septal defects

Philippe Acar; Cleo Laskari; Jonathan Rhodes; Natesa G. Pandian; Kenneth G. Warner; Gerald R. Marx

Mitral regurgitation (MR) is a significant complication after atrioventricular septal defect (AVSD) surgery. The relation of the valve leaflet morphology and the MR mechanism remains a conundrum. Two-dimensional echocardiography depicts leaflet edges, whereas volume-rendered 3-dimensional echocardiography provides direct visualization of the surface areas of the mitral valve leaflets. This study examines the relation of mitral valve anatomy as determined by 3-dimensional echocardiography with MR origins in patients after AVSD repair. Twenty-seven patients with AVSD surgery and Doppler color MR were prospectively enrolled (median age was 5 years and 16 patients had Down syndrome). Doppler color flow imaging of the MR jet and 3-dimensional echocardiography of the mitral valve were performed with a probe in the transthoracic or transesophageal position. Enface 3-dimensional views of the mitral valve from the left atrium were reconstructed. Analysis of the 3-dimensional data was possible in 21 of the 27 patients. Mean area ratios of the 3 mitral leaflets were calculated (superior 40 +/- 7%, inferior 35 +/- 5%, mural 25 +/- 6%). Both intra and interobserver variability on the area measurements were <5%. In 12 patients (group 1) the jet appeared to emanate medially from the region of coaptation of the superior and inferior components of the anterior leaflet. In 9 patients (group 2) the jet emanated more laterally from the region toward the mural leaflet. The area ratios of the inferior leaflet were 32 +/- 4% in group 1 and 38 +/- 6% in group 2 (p = 0.02). The area ratios of the mural leaflet were 28 +/- 5% in group 1 and 21 +/- 5% in group 2 (p = 0.007). The superior leaflet area ratio was not different in groups 1 and 2, 40 +/- 9% and 41 +/- 6%, respectively. Three-dimensional echocardiography provides new insight into the anatomic determinants of MR following AVSD surgery.


Circulation | 1997

Three-Dimensional Echocardiographic Estimation of Infarct Mass Based on Quantification of Dysfunctional Left Ventricular Mass

Jiefen Yao; Qi-Ling Cao; Navroz Masani; Alain Delabays; Giuseppina Magni; Philippe Acar; Cleo Laskari; Natesa G. Pandian

BACKGROUND Two-dimensional echocardiography is useful for estimating the extent of infarct-related wall motion abnormalities. Such estimation, however, is based on a few selected views and extrapolated for the whole left ventricle (LV). This approach does not provide us with the actual amount of dysfunctional myocardium. Volume-rendered three-dimensional echocardiography (3DE) might overcome these limitations. In this study we explored (1) how well volume-rendered 3DE delineates regional dysfunction of the infarcted LV and (2) how well dysfunctional myocardial mass quantified by 3DE reflects the actual anatomic infarct mass. METHODS AND RESULTS 3DE was performed before and 3 hours after coronary occlusion in 16 dogs. With the LV viewed in equidistant short-axis slices, the region of dysfunction was demarcated, and the dysfunctional myocardial mass was derived from this. With triphenyltetrazolium chloride staining, anatomic infarct regions were delineated, dissected, and weighed. The anatomic infarct mass was 16.3+/-7.7 g (mean+/-SD) (range, 6.4 to 31.4 g); the dysfunctional mass estimated by 3DE was 17.4+/-9.1 g (range, 5.2 to 39.0 g). The mean difference was 1.0 g. The correlation between dysfunctional mass (y) and infarct mass (x) was y=l.lx-0.6, r=.93 (P<.0001). The percentage of LV involved in infarction was 18.2+/-5.8% (range, 9.1% to 26.1%); the percentage of LV involved in regional dysfunction was 18.3+/-6.9% (range, 7.9% to 31.2%). The mean difference was 0.1%. The correlation between percentage of LV involved in infarction (x) and percentage of LV involved in dysfunction (y) was y=1.0x-1.1, r=.92 (P<.0001). CONCLUSIONS Volume-rendered 3DE crisply displays regional dysfunction of infarcted LV. 3DE-measured dysfunctional mass accurately reflects the anatomic infarct mass.


Cardiovascular Journal of Africa | 2014

Ross procedure in a child with Aspergillus endocarditis and bicuspid aortic valve : online article - case report

Fotios Mitropoulos; Meletios A. Kanakis; Constantinos Contrafouris; Cleo Laskari; Spyridon Rammos; Christos Apostolidis; Prodromos Azariadis; Andrew C. Chatzis

The case is presented of a previously healthy infant with a known asymptomatic bicuspid aortic valve who developed fungal endocarditis. The patient underwent aortic root replacement with a pulmonary autograft (Ross procedure). Cultured operative material revealed Aspergillus infection. The patient had an excellent recovery and remained well one year later.


Cardiovascular Journal of Africa | 2014

Ross procedure in a child with Aspergillus endocarditis and bicuspid aortic valve : case report

Fotios Mitropoulos; Meletios A. Kanakis; Constantinos Contrafouris; Cleo Laskari; Spyridon Rammos; Christos Apostolidis; Prodromos Azariadis; Andrew C. Chatzis

The case is presented of a previously healthy infant with a known asymptomatic bicuspid aortic valve who developed fungal endocarditis. The patient underwent aortic root replacement with a pulmonary autograft (Ross procedure). Cultured operative material revealed Aspergillus infection. The patient had an excellent recovery and remained well one year later.


Journal of the American College of Cardiology | 1996

Contrast three-dimensional echocardiography in acute myocardial infarction: 3-D reconstruction of perfusion defects yields accurate estimate of infarct mass and extent

Alain Delabays; Qi-Ling Cao; Jiefen Yao; Giuseppina Magni; Ajay Kanojia; Philippe Acar; Cleo Laskari; Navroz Masani; S. J. Schwartz; Natesa G. Pandian


Coronary Artery Disease | 1996

Three-dimensional echocardiography in mitral regurgitation.

Cleo Laskari; Navroz Masani; Natesa G. Pandian


Journal of the American College of Cardiology | 1996

How well does 3-dimensional echocardiographic quantification of dysfunctional left ventricular mass reflect actual anatomic infarct mass? Experimental studies

Jiefen Yao; Qi-Ling Cao; Alain Delabays; Giuseppina Magni; Philippe Acar; Cleo Laskari; Navroz Masani; Mark Aronovitz; Mani A. Vannan; Natesa G. Pandian


Journal of the American College of Cardiology | 1996

Accurate estimation of left ventricular mass in vivo by voxel-based three-dimensional echocardiography

Cleo Laskari; Alain Delabays; Jiefen Yao; Qi-Ling Cao; Giuseppina Magni; Stefano De Castro; Philippe Acar; Mani A. Vannan; S. J. Schwartz; Natesa G. Pandian


Cardiovascular Intervention and Therapeutics | 2018

Large single centre experience with the Cera™ and CeraFlex™ occluders for closure of interatrial communications: usefulness of the flexible rotation feature

Sotiria C. Apostolopoulou; Alexandros Tsoutsinos; Cleo Laskari; Maria Kiaffas; Spyridon Rammos

Collaboration


Dive into the Cleo Laskari's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Philippe Acar

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giuseppina Magni

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gerald R. Marx

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mani A. Vannan

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge